Table 1.
Participants’ characteristics
| Variable | No. of subjects | % |
|---|---|---|
| 716 | 100 | |
| Demographics | ||
| Age (mean, SD) | 70.5 (12.2) | |
| Sex (male) | 385 | 53.8 |
| Race/ethnicity | ||
| European American | 599 | 83.7 |
| African American | 47 | 6.6 |
| Asian American | 27 | 3.8 |
| Hispanic | 38 | 5.3 |
| Other | 5 | 0.7 |
| Education (≥10 years) | 418 | 58.4 |
| ICH location | ||
| Lobar | 323 | 45.1 |
| Non-lobar | 393 | 54.9 |
| Pre-ICH medical history | ||
| Hypertension | 531 | 74.2 |
| Ischaemic heart disease | 129 | 18.0 |
| Atrial fibrillation | 131 | 18.3 |
| Diabetes | 138 | 19.3 |
| Pre-ICH dementia | 64 | 8.9 |
| Pre-ICH mood disorder | 99 | 13.8 |
| Pre-ICH gait impairment | 34 | 4.8 |
| Prior ICH (before index event) | 37 | 5.2 |
| Prior ischaemic stroke/TIA | 85 | 11.9 |
| APOE genotype | ||
| APOE ɛ2 (frequency) | 0.09 | |
| APOE ɛ4 (frequency) | 0.19 | |
| Post-ICH medication use | ||
| Antiplatelet agents | 115 | 16.0 |
| Warfarin | 75 | 10.5 |
| Statins | 278 | 38.8 |
| Antihypertensive agents | 509 | 71.0 |
| SSRI | 236 | 32.9 |
ICH = intracerebral haemorrhage; SSRI = selective serotonin reuptake inhibitors.